)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
Lisata Therapeutics (LSTA) investor relations material
Lisata Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary7 Aug, 2025
Executive summary
Achieved key clinical and corporate milestones, including new research agreements and strategic alliances in Q2 2025.
Focused on developing certepetide, a novel agent for solid tumors, with multiple ongoing global Phase 2 trials and promising preliminary results from ASCEND and iLSTA.
Leadership team has extensive biopharma experience; strategy includes pipeline advancement and out-licensing.
Cash runway extends into Q4 2026, supporting all current clinical programs through next data milestones.
Multiple ongoing and planned clinical studies with anticipated data-rich period over the next 12 months.
Financial highlights
Q2 2025 revenue was $70,000 from an upfront license agreement with Catalent; no revenue in Q2 2024.
Operating expenses decreased 10.6% year-over-year to $4.9M, mainly due to lower R&D and G&A costs.
Net loss for Q2 2025 was $4.7M, down from $5.0M in Q2 2024; net loss for six months was $9.4M, down from $10.4M.
Cash, equivalents, and marketable securities totaled $22M as of June 30, 2025, supporting operations into 2026.
Working capital was $20.6M and stockholders' equity was $21.0M at quarter end.
Outlook and guidance
Cash and marketable securities expected to fund operations for at least the next 12 months and into Q4 2026.
Anticipates a data-rich 12 months with several key clinical milestones and readouts from ASCEND, BOLSTER, CENDIFOX, and iLSTA trials.
Additional financing likely needed by late 2026 for long-term needs; company seeks non-dilutive funding and partnerships.
Ongoing clinical trials progressing as planned, but some new studies remain on hold to manage capital.
$10M milestone payment expected upon Qilu's progression of certepetide to Phase 3 in China.
Phase III funding plans beyond current runway?
What is the rationale for capping BOLSTER 2nd-line?
How does new patent strengthen certepetide IP?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Lisata Therapeutics earnings date
Q3 202511 Nov, 2025
Next Lisata Therapeutics earnings date
Q3 202511 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
)
Edge19 Sep 2025
American Express: An Empire of Plastic
How history, brand, and structure have steadily built American Express' moat, and why Warren Buffett still calls it a one-of-a-kind business.
Frequently asked questions
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cell-based therapies for the treatment of advanced-stage diseases. The company's research and development efforts are primarily centered on addressing unmet medical needs in oncology, cardiovascular, and other serious conditions. Lisata leverages its proprietary technologies to create therapeutic solutions that promote tissue repair and regeneration. The company serves the healthcare sector with a focus on advancing treatments in areas where current options are limited. The company is headquartered in Basking Ridge, New Jersey, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage